CYTK
Cytokinetics, Incorporated
Stock
$65.62−0.29 (−0.44%)Close Oct 1, 2026
| Stock-based compensation (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $127M | +24.0% | 44.8% | 37.7% |
| Stock-based compensation (TTM) | $127M |
|---|---|
| YoY | +24.0% |
| 5-year CAGR | 44.8% |
| 10-year CAGR | 37.7% |
Stock-based compensation
| Period | Stock comp | YoY |
|---|---|---|
| 2025 | $112M | +14.8% |
| 2024 | $98M | +35.8% |
| 2023 | $72M | +50.6% |
| 2022 | $48M | +78.3% |
| 2021 | $27M | +52.3% |
| 2020 | $18M | +63.8% |
| 2019 | $11M | +10.2% |
| 2018 | $9.8M | +8.1% |
| 2017 | $9.0M | +26.3% |
| 2016 | $7.1M | +56.5% |
| 2015 | $4.6M | +37.1% |
| 2014 | $3.3M | −7.4% |
| 2013 | $3.6M | −4.9% |
| 2012 | $3.8M | +23.3% |
| 2011 | $3.1M | −23.6% |
| 2010 | $4.0M | −18.1% |
| 2009 | $4.9M | — |